The other study that I wanted to touch upon for this elecoglipron agent is VISTA, which is obesity without diabetes
Exogenous GLP-1 effectively lowers glucose in critically ill patients on enteral feeding by stimulating insulin secretion and slowing gastric emptying, which may increase gastric acid exposure and impact the mucosa of the stomach and duodenum [4]
Studies examining global DNA methylation in GHK-Cu-treated cells have identified altered methylation status at specific CpG sites within promoter regions of genes involved in matrix metabolism and inflammatory responses
Clinical studies on NAC + Glycine (GlyNAC) combinations have shown measurable improvements in glutathione levels, oxidative stress, and cognitive function in as little as 412 weeks
This is the data-gathering phase of your treatment journey
So they're much, much, much larger molecule compared to the small peptides